Who Exports Cladribine from India — 50 Suppliers Behind a $232.8K Market
India's cladribine export market is supplied by 50 active exporters who collectively shipped $232.8K across 125 shipments. RMPL PHARMA LLP leads with a 16.0% market share, followed by GNH INDIA PHARMACEUTICALS LIMITED and TRIKAYA GLOBAL. The top 5 suppliers together control 34.9% of total export value, reflecting a moderately competitive market structure.
Top Cladribine Exporters from India — Ranked by Export Value
RMPL PHARMA LLP is the leading cladribine exporter from India, holding a 16.0% share of the $232.8K market across 125 shipments from 50 exporters. The top 5 suppliers — RMPL PHARMA LLP, GNH INDIA PHARMACEUTICALS LIMITED, TRIKAYA GLOBAL, RIZLIFE HEALTHCARE, ATLAS ENTERPRISES — collectively control 34.9% of total export value, indicating a competitive market. Individual shares are: RMPL PHARMA LLP (16.0%), GNH INDIA PHARMACEUTICALS LIMITED (5.4%), TRIKAYA GLOBAL (5.1%), RIZLIFE HEALTHCARE (4.6%), ATLAS ENTERPRISES (3.7%).
Top Cladribine Exporters from India
Ranked by export value · 50 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | RMPL PHARMA LLP CLADRIM 10MGCLADRIM 10MG VIAL CLADRIBINE 90 VIALSCLADRIM 10MG/10ML INJ | $37.3K | 1 | 16.0% |
| 2 | GNH INDIA PHARMACEUTICALS LIMITED CLADRIM CLADRIBINE/1MG/ML X 10 ML (INJECCLADRIM CLADRIBINE 1MG 1MLX10ML BATCH 87240352AA 87240353AACLADRIM CLADRIBINE/1MG/ML X 10 ML BATCH | $12.5K | 1 | 5.4% |
| 3 | TRIKAYA GLOBAL CLADRIM 10MGCLADRIM 10MG VIAL CLADRIBINE 90 VIALSCLADRIM 10MG/10ML INJ | $12.0K | 1 | 5.1% |
| 4 | RIZLIFE HEALTHCARE PHARMACEUTICAL PRODUCTS.CLADRIM 10 MG INJCLADRIM 10MG INJECTION - CLADRIBINE 10MGCLADRIM 10MGCLADRIBINE | $10.7K | 2 | 4.6% |
| 5 | ATLAS ENTERPRISES CLADRIM INJ CLADRIBINEHARMLESS GOODS CLADRIBINE 10MG/10ML(CLCLADRIM 10 MG INJC CLADRIBINE 10MG/10ML | $8.6K | 2 | 3.7% |
| 6 | DOSHI MEDICARE PRIVATE LTD | $8.5K | 1 | 3.7% |
| 7 | R B INTERNATIONAL CLADRIM 10MGCLADRIM 10MG VIAL CLADRIBINE 90 VIALSCLADRIM 10MG CLADRIBINE | $7.7K | 1 | 3.3% |
| 8 | KINGS GLOBAL BIOTECH LIMITED CLADRIM CLADRIBINE/1MG/ML X 10 ML (INJECCLADRIM CLADRIBINE 1MG 1MLX10ML BATCH 87240352AA 87240353AACLADRIM CLADRIBINE/1MG/ML X 10 ML BATCH | $6.9K | 1 | 3.0% |
| 9 | 3S PHARMACEUTICALS INDIA PRIVATE LIMITED CLADRIBINE INJECTION 10MG 10ML BATCH 87240353AACLADRIM 10 MG INJ ,PACK-21 X VIAL | $6.7K | 2 | 2.9% |
| 10 | STAR ENTERPRISES CLADRIBINE INJECTION 10MG 10ML BATCH 87240353AACLADRIM 10 MG INJ ,PACK-21 X VIAL | $6.2K | 1 | 2.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Cladribine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| GNH India Pharmaceuticals Limited | Not Listed | Yes | Yes | Not verified | GNH India operates WHO-GMP and EU GMP certified facilities, ensuring compliance |
| Lee Pharma Limited | Approved | Yes | Yes | Not verified | Lee Pharma's manufacturing facilities are approved by USFDA, WHO-GMP, and EU GMP |
| Intas Pharmaceuticals Limited | Approved | Yes | Yes | Not verified | Intas Pharmaceuticals holds approvals from USFDA, WHO-GMP, and EU GMP, indicatin |
| GM Pharma | Not Listed | Yes | Yes | Not verified | GM Pharma's facilities are certified under WHO-GMP and EU GMP standards, ensurin |
| Centaur Pharmaceuticals Pvt. Ltd. | Not Listed | Yes | Not Listed | Not verified | Centaur Pharmaceuticals holds a WHO-GMP certification valid until December 1, 20 |
| Aarti Drugs Limited | Not Listed | Yes | Not Listed | Not verified | Aarti Drugs has a WHO-GMP certification valid until May 27, 2028, according to M |
| Ripcord Pharmaceuticals Pvt. Ltd. | Not Listed | Yes | Not Listed | Not verified | Ripcord Pharmaceuticals holds a WHO-GMP certification valid until September 8, 2 |
| US Pharma (I) Pvt. Ltd. | Not Listed | Yes | Not Listed | Not verified | US Pharma has a WHO-GMP certification valid until August 9, 2026, according to M |
TransData Nexus reviewed the regulatory standing of 8 leading Cladribine exporters from India. 2 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 4 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Cladribine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," hosts numerous pharmaceutical companies specializing in the production of Active Pharmaceutical Ingredients (APIs). The city's well-established infrastructure and skilled workforce make it a pivotal hub for API manufacturing. While specific data on Cladribine production in Hyderabad is limited, the city's prominence in API manufacturing suggests potential capabilities in producing such specialized compounds.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies like Cadila Pharmaceuticals, headquartered in Ahmedabad, have extensive operations in this region. Cadila Pharmaceuticals manufactures a range of products, including APIs and finished formulations. Additionally, Concord Biotech, based in Ahmedabad, specializes in fermentation-based biopharmaceutical APIs. These companies' presence indicates the region's capacity to produce complex pharmaceutical products, potentially including Cladribine.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. This region's proximity to major ports facilitates efficient international distribution. While specific Cladribine manufacturers in this area are not identified, the region's robust export infrastructure supports the distribution of pharmaceutical products, including Cladribine, to global markets.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is known for its tax incentives, attracting numerous pharmaceutical manufacturers. The region's favorable policies have led to the establishment of various production facilities. However, specific information regarding Cladribine production in this cluster is not readily available.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top 10 suppliers account for 52.4% of Cladribine exports, consider engaging with multiple suppliers to mitigate risks associated with over-reliance on a few sources.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and regulatory compliance of potential suppliers, especially those in established pharmaceutical clusters like Hyderabad and Ahmedabad-Vadodara, to ensure consistent quality and supply.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad region to streamline logistics and reduce lead times for international shipments.
- Monitor Regulatory Changes: Stay informed about tax incentives and regulatory policies in regions like Baddi-Nalagarh to capitalize on cost-saving opportunities and ensure compliance with local regulations.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Cladribine exporters from India
RK Pharma Inc. — RK Pharma Completes Acquisition of VGYAAN Pharmaceuticals
RK Pharma Inc., a vertically integrated pharmaceutical company, announced the successful acquisition of VGYAAN Pharmaceuticals LLC. This strategic move aims to enhance RK Pharma's product portfolio and strengthen partnerships. - IMPACT: While not directly related to Cladribine, this acquisition reflects the industry's trend towards consolidation, potentially influencing market dynamics.
Impact: While not directly related to Cladribine, this acquisition reflects the industry's trend towards consolidation, potentially influencing market dynamics.
KKR — KKR Acquires Majority Stake in Healthcare Global Enterprises Limited
KKR acquired a 51%-54% equity stake in Healthcare Global Enterprises Limited, becoming the largest shareholder and assuming sole control. This transaction triggered an open offer under the Takeover Regulations. - IMPACT: This significant investment underscores the attractiveness of the Indian healthcare sector to global investors, potentially affecting investment flows and competitive dynamics.
Impact: This significant investment underscores the attractiveness of the Indian healthcare sector to global investors, potentially affecting investment flows and competitive dynamics.
Sun Pharmaceutical Industries Limited — Sun Pharma Acquires Checkpoint Therapeutics for $355 Million
Sun Pharma announced the acquisition of Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. This move aims to bolster Sun Pharma's oncology portfolio. - IMPACT: This acquisition enhances Sun Pharma's position in the oncology market, potentially influencing competitive strategies within the pharmaceutical sector.
Impact: This acquisition enhances Sun Pharma's position in the oncology market, potentially influencing competitive strategies within the pharmaceutical sector.
Common Questions — Cladribine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which cladribine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, RMPL PHARMA LLP leads with 5 recorded shipments worth $37.3K. GNH INDIA PHARMACEUTICALS LIMITED (6 shipments) and TRIKAYA GLOBAL (7 shipments) are also established high-volume exporters.
Q How many cladribine manufacturers are there in India?
India has 50 active cladribine exporters with a combined export market of $232.8K across 125 shipments to 29 countries. The top 5 suppliers hold 34.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for cladribine from India?
Average FOB unit price: $116.50 per unit, ranging from $0.40 to $221.99. Average shipment value: $1.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 50 verified Indian exporters of Cladribine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 125 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 29 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
125 Verified Shipments
50 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists